Managing Pulmonary Arterial Hypertension and Optimizing Treatment Options PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Managing Pulmonary Arterial Hypertension and Optimizing Treatment Options PDF full book. Access full book title Managing Pulmonary Arterial Hypertension and Optimizing Treatment Options by Victor F. Tapson. Download full books in PDF and EPUB format.
Author: Victor F. Tapson
Publisher:
ISBN:
Category :
Languages : en
Pages : 24
Get Book Here
Book Description
Author: Victor F. Tapson
Publisher:
ISBN:
Category :
Languages : en
Pages : 24
Get Book Here
Book Description
Author: Bryan J. Wells
Publisher: Springer Nature
ISBN: 3030478688
Category : Medical
Languages : en
Pages : 545
Get Book Here
Book Description
This book serves as a pocket-sized resource to aid with the diagnosis and management of cardiovascular disease in the inpatient setting. Containing up-to-date information from guidelines and clinical trials, this book is the only handbook-style reference on cardiac care designed specifically for the hospitalist. The first section of the book covers cardiac pathology with an emphasis on evidence-based and guideline-based approaches to patient care. Each chapter focuses on a specific cardiovascular disease state such as acute coronary syndrome, atrial fibrillation, pulmonary hypertension, and aortic disease. The second section examines the differential diagnoses and recommended workup for common cardiac chief complaints including chest pain, palpitations, syncope, and dyspnea. The third and final section discusses indications and interpretation of commonly used cardiac procedures and imaging modalities. This book provides a concise review over a broad range of cardiovascular disease states in an accessible handbook-style to aid with the care of these patients. The Handbook of Inpatient Cardiology is an essential resource for physician hospitalists caring for cardiac patients on the medical ward in addition to cardiology physicians and trainees, affiliate providers, and students.
Author: Agency for Healthcare Resea And Quality
Publisher: Createspace Independent Publishing Platform
ISBN: 9781491081204
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
Pulmonary arterial hypertension (PAH), a subcategory of pulmonary hypertension (PH), is a rare and progressive disease whose prevalence is estimated to be between 15 and 50 cases per 1 million adults. While the pathophysiology is not well understood, both genetic and environmental factors have been found to contribute to changes in the pulmonary vasculature, causing increased pulmonary vascular resistance. This increased resistance, if unrelieved, progresses to right ventricular pressure overload, dysfunction, and ultimately right heart failure and premature death. Before the availability of disease-specific therapy in the mid-1980s, the median life expectancy at the time of diagnosis was 2.8 years. There are two separate populations for which screening for PAH needs to be considered. First, there are patients with symptoms that raise the suspicion of PAH. The symptoms of PAH can be insidious and nonspecific and may include shortness of breath, fatigue, weakness, chest pain, syncope, leg swelling, and abdominal distention. Symptoms that are present at rest suggest advanced disease. Since these symptoms are nonspecific, screening may be necessary to help the physician decide whether the patient should undergo a diagnostic workup for PAH, or whether other conditions should be considered. The other population is patients with medical conditions that put them at risk for PAH. In these patients screening tests may be used to identify patients with asymptomatic elevation of pulmonary artery pressures, who might be more closely monitored for the development of symptoms or progressive disease or offered a diagnostic workup for PAH and possibly treatment for early disease. This comparative effectiveness review was funded by the Agency for Healthcare Research and Quality (AHRQ). It was designed to evaluate the comparative validity, reliability, and feasibility of echocardiography and biomarker testing for the diagnosis and management of PAH in addition to clarifying whether the use of echocardiography and biomarkers affects decisionmaking and clinical outcomes. We also wanted to address which medications are effective for treating PAH and how the newer medications compare with older ones and with each other. Further, there was a need for clarity about whether combination therapy is more effective than monotherapy and what effect monotherapy or combination therapy has on intermediate-term and long-term outcomes. The Key Questions (KQs) considered in this comparative effectiveness review were: KQ 1: For patients with suspected pulmonary arterial hypertension (PAH) and asymptomatic patients at high risk for PAH, what are the comparative effectiveness and safety of echocardiography versus echocardiography plus biomarkers as screening modalities before right heart catheterization to establish the diagnosis of PAH (i.e., what is their comparative diagnostic accuracy efficacy)? KQ 2: For patients with PAH, what are the comparative effectiveness and safety of (a) echocardiography versus biomarkers and (b) echocardiography versus echocardiography plus biomarkers in managing PAH and on intermediate-term (90 days or less) and long-term (more than 90 days) patient outcomes? KQ 3: For patients with PAH, what are the comparative effectiveness and safety of monotherapy or combination therapy for PAH using calcium channel blockers, prostanoids, endothelin receptor antagonists, or phosphodiesterase inhibitors on intermediate-term and long term patient outcomes?
Author: Robyn Barst
Publisher: Wiley
ISBN: 9780470721483
Category : Medical
Languages : en
Pages : 272
Get Book Here
Book Description
First book dedicated to this disease, previously thought to be incurable, but with the advent of new drugs, now amenable to management and a much improved prognosis for patientsFrom the PAH Association, the leading experts in fieldIncorporates the latest AACP management guidelinesIncludes evidence-based treatment algorithms based on the recently updated ACCP Guidelines for Medical TreatmentAimed at specialists in pulmonology and cardiovascular disease, this volume provides the clinician with the most up to date information on the effective management of PAH
Author: Lewis J. Rubin
Publisher: CRC Press
ISBN: 9780824795054
Category : Medical
Languages : en
Pages : 384
Get Book Here
Book Description
Detailing state-of-the-art developments in the various aspects of primary pulmonary hypertension (PPH), this practical reference explores the history, most current scientific concepts, and treatments of this disease. Includes new advances not yet formally published! Written by nearly 30 of the top international experts in the field, Primary Pulmonary Hypertension addresses the general histological features of the normal and hypertensive pulmonary vasculature and the pathology of PPH discusses etiological possibilities of pathogenesis, common morphological features, and findings in experimental models examines risks factors for PPH and looks separately at familial PPH and PPH in children presents an approach to the differential diagnosis of pulmonary hypertension, emphasizing the recognition of PPH elucidates the invasive and noninvasive modalities available for obtaining qualitative and quantitative hemodynamic data for the diagnosis of PPH covers a variety of therapeutic options and much more!
Author: Celia Oakley
Publisher: John Wiley & Sons
ISBN: 0470994940
Category : Medical
Languages : en
Pages : 368
Get Book Here
Book Description
The new edition of this practical guide draws on the clinical skills of a wide range of international experts to help you recognize and manage heart disease in pregnancy. Designed for on-the-spot use, this convenient and concise text helps you identify a cardiac problem, understand its pathophysiology, and respond appropriately. Under the careful editorial direction of Drs. Oakley and Warnes, the Second Edition introduces new contributors from North America and Europe as well as new chapters on: pulmonary hypertension rheumatic heart disease artificial heart valves Marfan syndrome auto-immune diseases hypertrophic cardiomyopathy rhythm disorders hypertension cardiac intervention The entire book is scrupulously updated to reflect the most current standards of care. The contributors – all recognized leaders in their respective fields – outline the pathway to diagnosis and appropriate management by a multi-disciplinary team. Although heart disease is the leading medical cause of maternal death, clinical trials in this population are few and the evidence base is small. The expert recommendations in Heart Disease in Pregnancy, Second Edition, are a welcome source of information for cardiologists, obstetricians, general practitioners, and all members of the patient care team.
Author: Sean P. Gaine
Publisher: Springer
ISBN: 1447123980
Category : Medical
Languages : en
Pages : 326
Get Book Here
Book Description
The heart and lung are intricately linked. When the heart is affected by disease, the lungs will often show some related pathological or clinical conditions and vice versa. Pulmonary heart disease is by definition a condition when the lungs cause the heart to fail. The left ventricle in combination with the other structures in the “left heart” pumps blood throughout the body. The right ventricle (and structures of the “right heart”) pumps blood to the lungs where it is oxygenated and returned to the left heart for distribution. In normal circumstances, the right heart pumps blood into the lungs without any resistance. The lungs usually have minimal pressure and the right heart easily pumps blood through. However when there is lung disease present, like emphysema, chronic obstructive lung disease (COPD) or pulmonary hypertension- the small blood vessels become very stiff and rigid. The right ventricle is no longer able to push blood into the lungs and eventually fails. This is known as pulmonary heart disease. Pulmonary heart disease is also known as right heart failure or cor pulmonale. The chief cause of right heart failure is the increase in blood pressure in the lungs (pulmonary artery).
Author: Stavros V. Konstantinides
Publisher: Springer Science & Business Media
ISBN: 1597452874
Category : Medical
Languages : en
Pages : 273
Get Book Here
Book Description
This practical volume highlights traditional, novel, and evolving aspects of the diagnosis and treatment of pulmonary embolism (PE). The contributors comprise an international team of experts. Important aspects of diagnosis, risk stratification, and differential treatment of patients with PE are presented in a concise, yet comprehensive manner. Emphasis is placed on specific issues related to PE, including pregnancy, cancer, thrombophilia, and air travel.
Author: C. Ronco
Publisher: Karger Medical and Scientific Publishers
ISBN: 3805594178
Category : Medical
Languages : en
Pages : 252
Get Book Here
Book Description
Fluid overload is often observed in patients with heart failure and secondary oliguric states. A thorough assessment of the fluid status of the patient may help guide the therapy and prevent complications induced by inappropriate therapeutic strategies.The present publication is divided into four parts: Definition and Classification, Pathophysiology, Diagnosis and Therapy. In the first section, the authors present new definitions for heart failure, acute kidney injury and cardiorenal syndromes to facilitate the process of understanding the complex link between the heart and the kidney. Subsequently, different conditions leading to fluid overload are described, followed by an account of emerging diagnostic tools, therapies and technologies devoted to the treatment of patients with severe fluid-related disorders. Clearly structured and written, the present book is a practical tool for physicians and professionals involved in the management and care of patients with combined heart and kidney disorders. Moreover, it also serves as a reference textbook for medical students, residents and fellows dealing in everyday practice with fluid overloaded and oliguric patients.
Author: Samy I. McFarlane
Publisher: Springer Science & Business Media
ISBN: 1603273573
Category : Medical
Languages : en
Pages : 196
Get Book Here
Book Description
Diabetes and hypertension have evolved as two of the modern day epidemics affecting millions of people around the world. These two common co-morbidities lead to substantial increase in cardiovascular disease, the major cause of morbidity and mortality of adults around the world. In Diabetes and Hypertension: Evaluation and Management, a panel of renowned experts address a range of critical topics -- from basic concepts in evaluation and management of diabetes and hypertension, such as dietary interventions, to evaluation and management of secondary hypertension in clinical practice. Other chapters focus on high cardiovascular risk populations such as those with coronary heart disease, chronic kidney disease and minority patients. In addition, evolving concepts and new developments in the field are presented in other chapters, such as prevention of type 2 diabetes and the epidemic of sleep apnea and its implication for diabetes and hypertension evaluation and management. An important title covering two of the most troubling disorders of our time, Diabetes and Hypertension: Evaluation and Management will provide the busy practitioner with cutting edge knowledge in the field as well as practical information that can translate into better care provided to the high-risk population of diabetics and hypertensive patients.
